Retatrutide, a triple agonist targeting gastric inhibitory polypeptide (GIP), GLP-1, and glucagon receptors, has achieved highly promising outcomes in its phase 2 trial [22], with weight loss up to 24%
These concerns are being addressed in a current phase 3, double-blind, randomized, placebo-controlled, multicenter study of Voxelotor (ClinicalTrials.gov Identifier: NCT03036813) (Vichinsky et al., 2019)
Right now, research doesn't support taking biotin to prevent hair loss unless you have a true deficiency
Its everything Ive been looking for
Jszbernyi M, Thurz B, Jayakumar AR, Schally AV (2024) The aggravating role of failing neuropeptide networks in the development of sporadic Alzheimers disease